Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Synthetic Biologics Company Profile (NYSE:SYN)

Consensus Ratings for Synthetic Biologics (NYSE:SYN) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $3.75 (150.00% upside)

Analysts' Ratings History for Synthetic Biologics (NYSE:SYN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/20/2014ZacksDowngradeNeutral$1.50ViewTweet This Rating  Share This Rating on StockTwits
3/19/2014Maxim GroupBoost Price TargetBuy$3.00 -> $6.00ViewTweet This Rating  Share This Rating on StockTwits
10/17/2013Noble FinancialInitiated CoverageBuy$3.50ViewTweet This Rating  Share This Rating on StockTwits
9/30/2013Maxim GroupInitiated CoverageBuy$3.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2013Ascendiant Capital MarketsInitiated CoverageBuy$2.25ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/19/2012 forward)